✦ LIBER ✦

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

✍ Scribed by Timothy F Feltes; Allison K Cabalka; H.Cody Meissner; Franco M Piazza; David A Carlin; Franklin H Top Jr.; Edward M Connor; Henry M Sondheimer; for the Cardiac Synagis Study Group

Book ID: 117849927
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 155 KB
Volume: 143
Category: Article
ISSN: 1097-6833
DOI: 10.1067/s0022-3476(03)00454-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palivizumab prophylaxis reduces hospital

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

✍ T.F. Feltes; A.K. Cabalka; C. Meissner 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Respiratory syncytial virus immune globu

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease

✍ Eric A.F. Simoes; Henry M. Sondheimer; Franklin H. Top Jr.; H.Cody Meissner; Rob 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Prophylaxis with palivizumab against res

Prophylaxis with palivizumab against respiratory syncytial virus infection in infants with congenital heart disease—who should receive it?

✍ Jan Sunnegårdh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Optimizing the delivery and use of a new

Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: A successful provincial respiratory syncytial virus prophylaxis program

✍ Andrew Warren; Joanne M. Langley; Wanda Thomas; Jeff Scott 📂 Article 📅 2007 🏛 Pulsus Group Inc 🌐 English ⚖ 251 KB